Comparing glaucoma medications and general demographics in a sample of glaucoma patients treated in private practice with nationwide registry data in Finland.
Parkkari Minna, Taipale Joonas, Uusitalo Hannu
AI Summary
Finnish private clinics effectively manage glaucoma with good IOP control and similar medication costs to public care, though more aggressive cases are typically handled by public hospitals.
Abstract
Purpose
To investigate the outpatient glaucoma care provided by Finnish private ophthalmologists and to compare this information with the data obtained from national databases.
Methods
The data were collected by 13 investigators in 27 centres in southern Finland. Patient demography, relevant systemic diseases, possible history of ocular surgery, duration of glaucoma, intraocular pressure (IOP) and type of glaucoma were registered. Ocular hypertensive medication(s) used during the last 6 months were recorded using the generic name coded by the current ATC/DDD index. The data were compared with a dataset obtained from the IMS Health database and the Social Insurance Institution of Finland (Kela).
Results
In total, 568 patients from private ophthalmology clinics were included. Mean age was 70 years (range 30-90 years), and the mean duration of glaucoma was 8.3 years. In general, IOP control was good (mean 16.9 mmHg). The average cost of glaucoma treatment for a single study patient was 336 euros per year. The findings obtained from the survey were similar to those of the nationwide databases, although fewer of the more aggressive glaucoma cases were managed in the private clinics examined during the study.
Conclusion
The study patients were treated effectively by private ophthalmologist. Their medication and the cost of medication were the same as in public clinics. Patients with aggressive glaucoma seem to be generally managed by public hospitals.
Shields Classification
Key Concepts5
In a study of 568 glaucoma patients treated in private ophthalmology clinics in southern Finland, intraocular pressure (IOP) control was good, with a mean IOP of 16.9 mmHg.
The average cost of glaucoma treatment for a single study patient in private ophthalmology clinics in southern Finland was 336 euros per year.
Findings from a study of glaucoma patients in private ophthalmology clinics in southern Finland were similar to those of nationwide databases regarding medication and cost, although fewer aggressive glaucoma cases were managed in the private clinics.
Patients with aggressive glaucoma appear to be generally managed by public hospitals in Finland, based on a comparison of private clinic data with nationwide databases.
In a study of glaucoma patients in private ophthalmology clinics in southern Finland, the mean age of 568 patients was 70 years (range 30-90 years), and the mean duration of glaucoma was 8.3 years.
Related Articles5
Economic and Clinical Burden Associated With Intensification of Glaucoma Topical Therapy: A US Claims-based Analysis.
Cohort StudyThe future is old - Patients with topical ocular hypotensive treatment in the Nordic region between 2008 and 2017 with projections for 2040.
Observational StudySurveillance of glaucoma medical therapy in a Glasgow teaching hospital: 26 years' experience.
Observational StudyDirect costs of glaucoma management following initiation of medical therapy. A simulation model based on an observational study of glaucoma treatment in Germany.
Observational StudyPatient persistency with topical ocular hypotensive therapy in a managed care population.
Cohort StudyIs this article assigned to the wrong chapter(s)? Let us know.